ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

Lombardi Recruits Adams-Campbell.

October 3, 2008

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

In Brief: Simone Named New Director At St. Jude; Schein To Leave Georgetown For Job At Smith-Kline

September 16, 1983